Transgenic animals in integrative biology: approaches and interpretations of outcome.

Technological innovations in methods for genetic manipulation of laboratory animals and in techniques for assessment of cardiovascular, respiratory, behavioral, and metabolic physiology in mouse models afford unprecedented opportunities for research in integrative biology. We provide here an overview of basic and advanced techniques for generation of transgenic mice and a discussion of how transgenic technology can be most advantageously applied to important physiological questions that can be addressed only within the intact organism.

[1]  T. Beaty,et al.  Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. , 1999, The Journal of clinical investigation.

[2]  M. Rudnicki,et al.  Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death , 1992, Cell.

[3]  J. Ross,et al.  Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Semenza,et al.  Hypoxia-inducible factor 1: from molecular biology to cardiopulmonary physiology. , 1998, Chest.

[5]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 , 1998 .

[6]  K. Rajewsky,et al.  Conditional gene targeting. , 1996, The Journal of clinical investigation.

[7]  B. Wold,et al.  Know Your Neighbors: Three Phenotypes in Null Mutants of the Myogenic bHLH Gene MRF4 , 1996, Cell.

[8]  Marth Jd Recent advances in gene mutagenesis by site-directed recombination. , 1996 .

[9]  M. Moskowitz,et al.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.

[10]  M. Rudnicki,et al.  MyoD or Myf-5 is required for the formation of skeletal muscle , 1993, Cell.

[11]  J. Robbins,et al.  Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. , 1991, The Journal of biological chemistry.

[12]  M. Martone,et al.  Chronic Phospholamban–Sarcoplasmic Reticulum Calcium ATPase Interaction Is the Critical Calcium Cycling Defect in Dilated Cardiomyopathy , 1999, Cell.

[13]  B. Williams,et al.  Knowing chops from chuck: roasting myoD redundancy. , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  P. Silver,et al.  MyoD is required for myogenic stem cell function in adult skeletal muscle. , 1996, Genes & development.

[15]  Daniel J. Garry,et al.  Mice without myoglobin , 1998, Nature.

[16]  M. Gassmann,et al.  Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. , 1998, Genes & development.

[17]  G. Fishman,et al.  Conditional transgene expression in the heart. , 1996, Circulation research.

[18]  M. Rudnicki,et al.  Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development , 1992, Cell.

[19]  K. Suemasu,et al.  Lung adenocarcinomas diagnosed by open lung or thoracoscopic vs bronchoscopic biopsy. , 1998, Chest.

[20]  R. Hammer,et al.  Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β 2m: An animal model of HLA-B27-associated human disorders , 1990, Cell.

[21]  M. Rosenfeld,et al.  Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. , 1996, Genes & development.

[22]  R. Hammer,et al.  The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. , 1998, Genes & development.

[23]  D. Ganten,et al.  Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene , 1990, Nature.

[24]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[25]  Y. Ouchi,et al.  Elevated blood pressure and craniofaclal abnormalities in mice deficient in endothelin-1 , 1994, Nature.